The Value of Atlas Antibodies Pan-Cancer Marker Collection
The Atlas Antibodies Pan-Cancer Marker Panel includes more than 300 antibodies for tissue and cell analysis. Each antibody is extensively validated across 20 human cancer types, ensuring robust performance and reliable results for comprehensive pan-cancer research.
Direct Protein Profiling
300+ antibodies: transcript levels don’t always reflect functional protein presence. Our antibodies allow direct detection of biologically relevant proteins.
High-Confidence
IHC-verified: all antibodies are validated through IHC on a wide panel of normal and cancer tissues to ensure specificity, consistency, and relevance.
Multi-Cancer Utility
20+ tumor types validated: targets are derived from cross-cancer analyses of human samples, making the collection ideal for broad, multiplexed cancer research.
Example of Pan-Cancer Markers
| Marker |
Role in Cancer |
Cancer Involvement |
View Product |
| KI-67 (MKI67) |
Proliferation marker; enriched in dividing tumor cells. |
Breast, lung, colorectal, prostate, glioma, sarcoma |
AMAb90870 |
| HER2 (ERBB2) |
Receptor tyrosine kinase; drives growth and survival. |
Breast, gastric, ovarian, lung |
AMAb90627 |
| EZH2 |
Epigenetic regulator; promotes stemness and tumor progression. |
Prostate, breast, lymphomas, sarcomas, melanoma |
AMAb91749 |
| CD44 |
Cell adhesion and migration; cancer stem cell-associated. |
Breast, colorectal, pancreatic, head & neck, prostate |
AMAb91845 |
| ERCC1 |
DNA repair protein; linked to chemo resistance (platinum agents). |
Lung, ovarian, bladder, colorectal |
AMAb90871 |
| ESR1 (ERα) |
Hormone receptor regulating proliferation and tumor growth. |
Breast, endometrial, ovarian |
AMAb90867 |
